Filing Details
- Accession Number:
- 0000950170-24-027334
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-06 17:21:12
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-06 17:21:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1178879 | Amicus Therapeutics Inc. | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1215126 | G Margaret Mcglynn | 47 Hulfish Street Princeton NJ 08542 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-04 | 7,500 | $2.80 | 66,789 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-04 | 7,500 | $13.29 | 59,289 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-03-05 | 7,500 | $2.80 | 66,789 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-05 | 7,500 | $13.40 | 59,289 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (right to buy) | Disposition | 2024-03-04 | 7,500 | $0.00 | 7,500 | $2.80 |
Common Stock | Stock Options (right to buy) | Disposition | 2024-03-05 | 7,500 | $0.00 | 7,500 | $2.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
7,500 | 2024-06-12 | No | 4 | M | Direct | |
0 | 2024-06-12 | No | 4 | M | Direct |
Footnotes
- All of the options were fully vested and exercisable as of the transaction date.